Advertisement

Topics

ViroPharma Incorporated Company Profile

14:56 EDT 25th September 2017 | BioPortfolio

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with serious diseases for which there is an unmet medical need, and providing rewarding careers to employees. ViroPharma commercializes Cinryze(TM) (C1 esterase inhibitor [human]) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE). ViroPharma commercializes Vancocin®, approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in diseases including C1 esterase inhibitor deficiency and C. difficile.


News Articles [12 Associated News Articles listed on BioPortfolio]

ViroPharma to Participate in the JMP Securities 2013 Healthcare Conference

EXTON, Pa., July 1, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the JMP S...

ViroPharma To Participate In The Stifel Nicolaus 2013 Healthcare Conference

EXTON, Pa., Sept. 9, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the company will present at the Stifel Nicolaus 2013 Healthcare Conference at 8:35 AM ET on Wednes...

ViroPharma To Participate In Two December Healthcare Investor Conferences

EXTON, Pa., Nov. 29, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the...

ViroPharma To Participate In Two June Healthcare Investor Conferences

EXTON, Pa., May 22, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Charles Rowland, vice president and chief financial officer of ViroPharma, will present at the Gold...

ViroPharma To Participate In Two May Healthcare Investor Conferences

EXTON, Pa., May 9, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Robert Doody, director of investor relations, will present at the 2013 Bank of America Merrill Lynch...

ViroPharma Provides Update on Industrial Scale Supplement for Cinryze® (C1 Esterase Inhibitor [Human])

EXTON, Pa., Feb. 7, 2012 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced the U.S Food and Drug Administration (FDA) issued a complete response letter regarding Cinryze&...

ViroPharma Receives Orphan Drug Designation For Maribavir In Europe

EXTON, Pa., June 11, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the European Commission has granted orphan drug designation for maribavir for treatment of cytomeg...

ViroPharma Provides 2013 Outlook

EXTON, Pa., Jan. 7, 2013 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will provide an overv...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

AERODYNAMIC PROPERTIES AND IN SILICO DEPOSITION OF MELOXICAM POTASSIUM INCORPORATED IN A CARRIER-FREE DPI PULMONARY SYSTEM.

Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...

Clinical Trials [0 Results]

None

Companies [38 Associated Companies listed on BioPortfolio]

ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with s...

ViroPharma Ltd.

Natural Handmade Cosmetics & Development in Biotechnology

ViroPharma

At ViroPharma, we are dedicated to transforming the lives of patients through the commercialization of new and important medicines. Our goal is to focus on developing and marketing innovative products...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

More Information about "ViroPharma Incorporated" on BioPortfolio

We have published hundreds of ViroPharma Incorporated news stories on BioPortfolio along with dozens of ViroPharma Incorporated Clinical Trials and PubMed Articles about ViroPharma Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ViroPharma Incorporated Companies in our database. You can also find out about relevant ViroPharma Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record